Browsing Public Health by Subject "Tocilizumab"
Now showing items 1-2 of 2
-
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
( Elsevier , 2021 , Article)ObjectivesCytokine release syndrome with elevated interleukin-6 (IL-6) levels is associated with multiorgan damage and death in severe coronavirus disease 2019 (COVID-19). Our objective was to perform a living systematic ... -
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update
( Elsevier , 2021 , Article)ObjectivesCytokine release syndrome with elevated interleukin-6 (IL-6) levels is associated with multiorgan damage and death in severe coronavirus disease 2019 (COVID-19). Our objective was to update the data in a living ...